U.S. Supreme Court Denies BDSI’s Petition for Certiorari Seeking to Require the U.S. PTAB to Reconsider Decision to Not Institute Inter Partes Reviews of Aquestive’s U.S. Patent No. 8,765,167, as Drafted/Prosecuted/Defended By Hoffmann & Baron
Aquestive Therapeutics, Inc.’s U.S. Patent No. 8,765,167 (“Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions”) is a cornerstone of Aquestive’s PharmFilm® rapidly-dissolving, thin-film pharmaceutical technology; the ‘167 Patent was…